Research graph
References from In recently relapsed polymyalgia rheumatica during GC tapering, secukinumab increased sustained remission rates at 1 y. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1056/nejmoa2303452
10.1056/nejmoa2303452 · External reference
10.1001/jama.2022.15459
10.1001/jama.2022.15459 · External reference
10.1002/art.43320
10.1002/art.43320 · External reference
10.1056/nejmcp2506817
10.1056/nejmcp2506817 · External reference
